Amgen : AMGN

All Amgen Articles

704 Articles

Chris Lange | Jan 5, 2022 at 11:45 AM EST

Wednesday Afternoon Analyst Upgrades and Downgrades: Altria, BP, Peloton, Pfizer and More

Wednesday afternoon's top analyst upgrades and downgrades included Adobe, Altria, Amgen, Beyond Meat, BP, Murphy Oil, Northrop Grumman, Occidental Petroleum,…

Paul Ausick | Jan 1, 2022 at 6:30 AM EST

2022’s Dogs of the Dow

Here's the final list of 2022's Dogs of the Dow.

Paul Ausick | Dec 28, 2021 at 10:12 AM EST

Meet the Preliminary Dogs of the Dow for 2022

Here is a look at the stocks currently in the running to be Dogs of the Dow for 2022.

Chris Lange | Dec 9, 2021 at 11:50 AM EST

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.

Lee Jackson | Dec 9, 2021 at 7:35 AM EST

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of…

Lee Jackson | Dec 6, 2021 at 8:53 AM EST

Monday’s Top Analyst Upgrades and Downgrades: Apple, AT&T, Chevron, Dollar General, Ford, Kroger, Marvell, Peloton, Salesforce, Twitter and More

Monday’s top analyst upgrades and downgrades included Amgen, Apple, AT&T, Chevron, Dollar General, Fastly, Ford, Hertz, Kroger, Marvell Technology, Peloton…

Chris Lange | Nov 19, 2021 at 11:45 AM EST

Friday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Amgen, Applied Materials, Delta Air, Macy’s, Snowflake, Walmart and More

Friday afternoon's analyst upgrades and downgrades included Alibaba, AIG, Amgen, Applied Materials, Bath & Body Works, Delta Air Lines, Kohl’s,…

Lee Jackson | Nov 18, 2021 at 7:35 AM EST

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets,…

Lee Jackson | Nov 5, 2021 at 7:35 AM EDT

5 Hard-Hit Dow Stocks Have Monster Upside and Come With Great Dividends

These five outstanding blue chip stocks have been hit hard this year and are offering growth and income investors incredible…

Lee Jackson | Oct 15, 2021 at 7:35 AM EDT

2 Large Cap Biotech Leaders Pay Big Dividends and Have Huge Upside Potential

While not suited for conservative income investors, these two top biotech stocks could have huge total return potential and offer…

Lee Jackson | Sep 23, 2021 at 8:50 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More

Thursday's top analyst upgrades and downgrades included Amgen, Biogen, Commscope, Lockheed Martin, Northrop Grumman, ONEOK, Plug Power and Roku.

Chris Lange | Sep 7, 2021 at 8:51 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma

Tuesday’s top analyst upgrades and downgrades included Amgen, Cirrus Logic, Hain Celestial, Johnson & Johnson, Lam Research, Merck, Spotify Technology…

Chris Lange | Aug 24, 2021 at 9:35 AM EDT

6 Stocks Marjorie Taylor Greene Is Buying

24/7 Wall St. takes a look at Georgia Representative Marjorie Taylor Greene and what stock trades are going on around…

Lee Jackson | Mar 17, 2021 at 7:59 AM EDT

Goldman Sachs Has 4 Tech and Biotech Stocks to Buy With Big-Time Growth Potential

With the first quarter soon coming to an end, now is the time to move from momentum to strong growth…

Chris Lange | Jan 31, 2021 at 10:00 AM EST

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

1 … 6 7 8 9 10 … 47

Amgen : AMGN

All Amgen Articles

Wednesday Afternoon Analyst Upgrades and Downgrades: Altria, BP, Peloton, Pfizer and More

2022’s Dogs of the Dow

Meet the Preliminary Dogs of the Dow for 2022

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Monday’s Top Analyst Upgrades and Downgrades: Apple, AT&T, Chevron, Dollar General, Ford, Kroger, Marvell, Peloton, Salesforce, Twitter and More

Friday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Amgen, Applied Materials, Delta Air, Macy’s, Snowflake, Walmart and More

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

5 Hard-Hit Dow Stocks Have Monster Upside and Come With Great Dividends

2 Large Cap Biotech Leaders Pay Big Dividends and Have Huge Upside Potential

Thursday’s Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More

Tuesday’s Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma

6 Stocks Marjorie Taylor Greene Is Buying

Goldman Sachs Has 4 Tech and Biotech Stocks to Buy With Big-Time Growth Potential

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week

Skip ARKK’s Moonshots: This Fund Owns the AI Software Winners for 0.45%

NVIDA Vs. Tesla: Tesla Jumps as It Finally Fulfills Decade-Old Promise So Buy Nvidia Instead

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

"Bro, 3 Years and the Finances Are Separate?": Caleb Hammer Confronts Married Couple With 4 Kids and a Past-Due Mortgage

Skip ARKK’s Moonshots: This Fund Owns the AI Software Winners for 0.45%

NVIDA Vs. Tesla: Tesla Jumps as It Finally Fulfills Decade-Old Promise So Buy Nvidia Instead

Amgen : AMGN

All Amgen Articles

Wednesday Afternoon Analyst Upgrades and Downgrades: Altria, BP, Peloton, Pfizer and More

2022’s Dogs of the Dow

Meet the Preliminary Dogs of the Dow for 2022

Thursday Afternoon’s Analyst Upgrades and Downgrades: AbbVie, Occidental Petroleum, Pfizer, Yum! Brands and More

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Monday’s Top Analyst Upgrades and Downgrades: Apple, AT&T, Chevron, Dollar General, Ford, Kroger, Marvell, Peloton, Salesforce, Twitter and More

Friday Afternoon’s Analyst Upgrades and Downgrades: Alibaba, Amgen, Applied Materials, Delta Air, Macy’s, Snowflake, Walmart and More

Health Care Stocks Cheapest in 30 Years: 5 With Big Dividends to Buy Now

5 Hard-Hit Dow Stocks Have Monster Upside and Come With Great Dividends

2 Large Cap Biotech Leaders Pay Big Dividends and Have Huge Upside Potential

Thursday’s Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More

Tuesday’s Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma

6 Stocks Marjorie Taylor Greene Is Buying

Goldman Sachs Has 4 Tech and Biotech Stocks to Buy With Big-Time Growth Potential

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week

Skip ARKK’s Moonshots: This Fund Owns the AI Software Winners for 0.45%

NVIDA Vs. Tesla: Tesla Jumps as It Finally Fulfills Decade-Old Promise So Buy Nvidia Instead

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

Featured Reads

The Dividend Growth Plan That Leaves High-Yield Stocks Behind

"Bro, 3 Years and the Finances Are Separate?": Caleb Hammer Confronts Married Couple With 4 Kids and a Past-Due Mortgage